PMC:7558233 / 28688-28915
Annnotations
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
757 | 186-194 | Species | denotes | patients | Tax:9606 |
787 | 14-29 | Disease | denotes | viral infection | MESH:D001102 |
788 | 47-53 | Disease | denotes | sepsis | MESH:D018805 |
789 | 106-114 | Disease | denotes | COVID-19 | MESH:C000657245 |
790 | 210-226 | Disease | denotes | critical illness | MESH:D016638 |
LitCovid-PD-HP
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T52 | 47-53 | Phenotype | denotes | sepsis | http://purl.obolibrary.org/obo/HP_0100806 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T174 | 0-227 | Sentence | denotes | The fact that viral infection (including viral sepsis) [79] remains the key driver of the pathogenesis of COVID-19 has fueled research exploring the efficacy of antiviral medications in patients with severe or critical illness. |
MyTest
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
33078078-32311318-28132408 | 56-58 | 32311318 | denotes | 79 |
2_test
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
33078078-32311318-28132408 | 56-58 | 32311318 | denotes | 79 |